Gilead, GSK/ViiV, Merck Present New HIV PrEP Frontiers at IAS25

By Leonardo Arias / 15/07/2025

HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the heels of the landmark Yeztugo approval.